Abstract
A double-blind, placebo-controlled study was conducted to evaluate the efficacy an ethanolic extract of Aswagandha (Withania somnifera), in patients with ICD-10 anxiety disorders. The sample comprised 39 subjects, of whom 20 received the drug and 19 received placebo. The two groups were sociodemographically and clinically similar at baseline. At 2 and 6 weeks follow-up, data from approximately 85% of patients in each group were available for analysis. Statistical trends favouring the drug were observed at both time points. At 6 weeks, significantly more patients met a priori response criteria in the drug group (88.2%) as compared with the placebo group (50%). The drug was well-tolerated and did not occasion more adverse effects than did placebo. It is concluded that this ethanolic extract of Withania somnifera has useful anxiolytic potential and merits further investigation.
Keywords: Anxiety disorder, generalized anxiety disorder, adjustment disorder with anxiety, panic disorder, Aswagandha, Ayurvedic treatment, herbal therapy, clinical trial
Full Text
The Full Text of this article is available as a PDF (297.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bech P., Kastrup M., Rafaelsen O. J. Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand Suppl. 1986;326:1–37. [PubMed] [Google Scholar]
- Kessler R. C., McGonagle K. A., Zhao S., Nelson C. B., Hughes M., Eshleman S., Wittchen H. U., Kendler K. S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994 Jan;51(1):8–19. doi: 10.1001/archpsyc.1994.03950010008002. [DOI] [PubMed] [Google Scholar]
- Londborg P. D., Wolkow R., Smith W. T., DuBoff E., England D., Ferguson J., Rosenthal M., Weise C. Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation. Br J Psychiatry. 1998 Jul;173:54–60. doi: 10.1192/bjp.173.1.54. [DOI] [PubMed] [Google Scholar]
- Mehta A. K., Binkley P., Gandhi S. S., Ticku M. K. Pharmacological effects of Withania somnifera root extract on GABAA receptor complex. Indian J Med Res. 1991 Aug;94:312–315. [PubMed] [Google Scholar]
- Schweizer E., Patterson W., Rickels K., Rosenthal M. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder. Am J Psychiatry. 1993 Aug;150(8):1210–1215. doi: 10.1176/ajp.150.8.1210. [DOI] [PubMed] [Google Scholar]